Project partners

The INTEGRATE-LMedC project comprises the following partners – each name expands with details:

Biobanks and BioMolecular Resources Research Infrastructure Consortium (BBMRI-ERIC)

Biobanking and biomolecular resources will be provided by BBMRI, which aims at improving the accessibility and interoperability of the existing comprehensive collections, either population-based or clinical-oriented, of biological samples from different (sub-) populations of Europe or rare diseases. BBMRI consists of 23 countries with strong links to more than 100 Cancer Centres and three affiliated Expert Centres. BBMRI-ERIC with its National Nodes and affiliated communities will further provide expertise and services in ELSI, IT, Quality Management, Training, Outreach and Public Affairs.  


Norges Teknisk-Naturvitenskapelige Universitet NTNU (NTNU)

NTNU is an international oriented university with headquarters in Trondheim and campuses in Gjøvik and Ålesund.

NTNU has a main profile in science and technology, a variety of programmes of professional study, and great academic breadth that also includes the humanities, social sciences, economics, medicine, health sciences, educational science, architecture, entrepreneurship, art disciplines and artistic activities. 

The university’s root goes back to 1760 with the foundation of Det Trondhiemske Selskab (Trondheim Academy). A merger in 2016 made NTNU Norway’s largest single university.


European Clinical Research Infrastructure Network (ECRIN)

ECRIN is a European Research Infrastructure facilitating multinational clinical research, through the provision of advice and services for the set-up and management of investigator or SME led clinical studies in Europe. ECRIN unites national networks of clinical trial units across Europe, through its scientific partners, to fulfil its vision of generating scientific evidence to optimise medical practice. By supporting clinical trials across borders and advising and implementing policy, ECRIN advances knowledge flow, competitiveness and integration in European clinical research.


Fundacio Privada per a la Recerca i la Docencia Sant Joan de Deu (FSJD-CERCA)

The primary goal of the Fundació de recerca Sant Joan de Déu is to contribute to the improvement of people’s health and well-being by promoting, supporting and coordinating research and innovation at the centres of the Hospitaller Order of Saint John of God ‒ Aragon-San Rafael Province, in accordance with its values: Hospitality, Respect, Quality, Responsibility and Spirituality).


Academisch Ziekenhuis Groningen (UMCG)

The UMCG (Academisch Ziekenhuis Groningen) is the second largest academic hospital in the Netherlands with a staff of 10,000 people in patient care, education & training and research, with a focus on ‘Healthy Ageing’. The work is planned at the Genomics Coordination Center (GCC) a bioinformatics core facility and big data stewardship hotel between the UMC/University of Groningen on on a mission to unlock the full potential of next-generation *omics, translational and biobank experiments towards personalised medicine and systems genetics for rare and common disease.


Masarykova Univerzita (MU)

Our mission is science and research. State-of-the-art equipment, cutting-edge technologies and international cooperation. This is what research at MU is all about. We are dedicated to establishing the right priorities, committed to securing sufficient funding and fully aware of the ethical and social implications of our research results.


QI.Lab.Med spin-off of Padova University (QI.LAB.MED)

Offers support to medical laboratories through quality assessment services for programs and advanced diagnostics of clinical laboratories. Establishing computer programs for quality indicators in laboratory analysis. Performs training courses and translational medicine research.


Fraunhofer Gesellschaft zur Forderung der Angewandtenc Forschung ev (Fraunhofer)

The Fraunhofer organisation is Europe’s largest application-oriented research organization. It’s research efforts are geared entirely to people’s needs: health, security, communication, energy and the environment. Fraunhofer IME is one of the Partner organisations of EU-OPENSCREEN, the European Infrastructure for Chemical Biology and Screening. The focus of Fraunhofer IME is to contribute steadily and substantially to the development of new approaches for the diagnosis and treatment of diseases. One research covers the development of bioinformatics and data management processes to help drug discovery and target validation. Areas of interest include FAIR and Federated data approaches, as well as the application of machine learning for hypothesis generation in target validation. For example, the Fraunhofer “Medical Data Space“ Modeled on the basic functionalities offered by the “Industrial Data Space“, the Medical Data Space offers decentralized data management for medical bioinformatics allowing autonomous and secure data storage as well as data exchange between networked databases.


HUS-yhtyma (HUS)

HUS is the biggest health care provider. Our expertise is internationally recognised and accredited. As a university hospital, we continuously develop and evaluate our treatment methods and activities.

We are responsible for organising specialised healthcare in the Uusimaa region. In addition, the treatment of many rare and severe diseases is nationally centralised to HUS.


Centre International de Recherche sur le Cancer (IARC)

IARC, the specialised cancer agency of the World Health Organization, will also join canSERV consortium. The Agency is inter-disciplinary, bringing together skills in epidemiology, laboratory sciences and biostatistics to identify the causes of cancer so that preventive measures may be adopted, and the burden of disease and associated suffering reduced. A significant feature of the IARC is its expertise in coordinating research across countries and organisations; its independent role as an international organisation facilitates this activity. The classification of human tumours as reported in the WHO “Blue Book” series is an additional resource of value to cancer researchers and clinicians worldwide. One of the products of IARC’s coordinating role is an increasingly important biobank with approximately 6 million samples from 600 000 subjects in total.



Accelerating collaborative brain research.

EBRAINS provides a digital research infrastructure that accelerates collaborative brain research between leading organizations and researchers across the fields of neuroscience, brain health, and brain-related technologies.